Innovative Antibody Developer Escugen Biotech Completes Pre-A Financing Round
On August 24, 2020, Shanghai Escugen Biotech Co., Ltd. (hereinafter referred to as "Escugen Biotech") announced that it has recently completed a Pre-A financing round of tens of millions of yuan.
2020-08-24
